Song, S., Guo, Y., Lin, Y., Gao, H., & Ren, H. (2025). Impact of Empagliflozin on Cardiovascular Outcomes and Renal Function in Patients with Obesity and Type 2 Diabetes. Diabetes Therapy: Research, treatment and education of diabetes and related disorders, 1. https://doi.org/10.1007/s13300-025-01753-4
Chicago Style (17th ed.) CitationSong, Shuxian, Yajv Guo, Yuan Lin, Haiyan Gao, and Hongxia Ren. "Impact of Empagliflozin on Cardiovascular Outcomes and Renal Function in Patients with Obesity and Type 2 Diabetes." Diabetes Therapy: Research, Treatment and Education of Diabetes and Related Disorders 2025: 1. https://doi.org/10.1007/s13300-025-01753-4.
MLA (9th ed.) CitationSong, Shuxian, et al. "Impact of Empagliflozin on Cardiovascular Outcomes and Renal Function in Patients with Obesity and Type 2 Diabetes." Diabetes Therapy: Research, Treatment and Education of Diabetes and Related Disorders, 2025, p. 1, https://doi.org/10.1007/s13300-025-01753-4.